-
1
-
-
33845872010
-
Problems of prophylactic vaccinations of infants
-
(In Italian)
-
Ritossa P: Problems of prophylactic vaccinations of infants. Riv Ist Sieroter Ital 37: 79-108, 1962 (In Italian).
-
(1962)
Riv Ist Sieroter Ital
, vol.37
, pp. 79-108
-
-
Ritossa, P.1
-
3
-
-
0027333423
-
Role of the major heat shock proteins as molecular chaperones
-
Georgopoulos C and Welch WJ: Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 9: 601-634, 1993.
-
(1993)
Annu Rev Cell Biol
, vol.9
, pp. 601-634
-
-
Georgopoulos, C.1
Welch, W.J.2
-
4
-
-
0026584271
-
Protein folding in the cell
-
Gething MJ and Sambrook J: Protein folding in the cell. Nature 355: 33-45, 1992.
-
(1992)
Nature
, vol.355
, pp. 33-45
-
-
Gething, M.J.1
Sambrook, J.2
-
5
-
-
0027135501
-
The function of heat-shock proteins in stress tolerance: Degradation and reactivation of damaged proteins
-
Parsell DA and Lindquist S: The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genet 27: 437-496, 1993.
-
(1993)
Annu Rev Genet
, vol.27
, pp. 437-496
-
-
Parsell, D.A.1
Lindquist, S.2
-
6
-
-
0034646515
-
Getting newly synthesized proteins into shape
-
Bukau B, Deuerling E, Pfund C and Craig EA: Getting newly synthesized proteins into shape. Cell 101: 119-122, 2000.
-
(2000)
Cell
, vol.101
, pp. 119-122
-
-
Bukau, B.1
Deuerling, E.2
Pfund, C.3
Craig, E.A.4
-
7
-
-
0035132104
-
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells
-
Castelli C, Ciupitu AM, Rini F, et al: Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res 61: 222-227, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 222-227
-
-
Castelli, C.1
Ciupitu, A.M.2
Rini, F.3
-
8
-
-
0028061311
-
Heat shock proteins and molecular chaperones: Mediators of protein conformation and turnover in the cell
-
Craig EA, Weissman JS and Horwich AL: Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell. Cell 78: 365-372, 1994.
-
(1994)
Cell
, vol.78
, pp. 365-372
-
-
Craig, E.A.1
Weissman, J.S.2
Horwich, A.L.3
-
9
-
-
0027208741
-
Tumor rejection antigen gp96/grp94 is an ATPase: Implications for protein folding and antigen presentation
-
Li Z and Srivastava PK: Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J 12: 3143-3151, 1993.
-
(1993)
EMBO J
, vol.12
, pp. 3143-3151
-
-
Li, Z.1
Srivastava, P.K.2
-
10
-
-
35548970287
-
Heat shock proteins in cancer
-
Sherman M and Multhoff G: Heat shock proteins in cancer. Ann N Y Acad Sci 1113: 192-201, 2007.
-
(2007)
Ann N Y Acad Sci
, vol.1113
, pp. 192-201
-
-
Sherman, M.1
Multhoff, G.2
-
11
-
-
1842869225
-
Heat shock protein 70: Role in antigen presentation and immune stimulation
-
Milani V, Noessner E, Ghose S, et al: Heat shock protein 70: role in antigen presentation and immune stimulation. Int J Hyperthermia 18: 563-575, 2002.
-
(2002)
Int J Hyperthermia
, vol.18
, pp. 563-575
-
-
Milani, V.1
Noessner, E.2
Ghose, S.3
-
12
-
-
0022534393
-
Tumor rejection antigens of chemically induced sarcomas of inbred mice
-
Srivastava PK, DeLeo AB and Old LJ: Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci USA 83: 3407-3411, 1986.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 3407-3411
-
-
Srivastava, P.K.1
DeLeo, A.B.2
Old, L.J.3
-
13
-
-
0034282811
-
Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells
-
Vanaja DK, Grossmann ME, Celis E and Young CY: Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. Cancer Res 60: 4714-4718, 2000.
-
(2000)
Cancer Res
, vol.60
, pp. 4714-4718
-
-
Vanaja, D.K.1
Grossmann, M.E.2
Celis, E.3
Young, C.Y.4
-
14
-
-
0030820099
-
Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations
-
Tamura Y, Peng P, Liu K, Daou M and Srivastava PK: Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278: 117-120, 1997.
-
(1997)
Science
, vol.278
, pp. 117-120
-
-
Tamura, Y.1
Peng, P.2
Liu, K.3
Daou, M.4
Srivastava, P.K.5
-
15
-
-
0032007324
-
Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96
-
Nicchitta CV: Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96. Curr Opin Immunol 10: 103-109, 1998.
-
(1998)
Curr Opin Immunol
, vol.10
, pp. 103-109
-
-
Nicchitta, C.V.1
-
16
-
-
39749186213
-
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 Study Group
-
Testori A, Richards J, Whitman E, et al: Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group. J Clin Oncol 26: 955-962, 2008.
-
(2008)
J Clin Oncol
, vol.26
, pp. 955-962
-
-
Testori, A.1
Richards, J.2
Whitman, E.3
-
17
-
-
46749085802
-
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: A multicentre, open-label, randomised phase III trial
-
Wood C, Srivastava P, Bukowski R, et al: An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial. Lancet 372: 145-154, 2008.
-
(2008)
Lancet
, vol.372
, pp. 145-154
-
-
Wood, C.1
Srivastava, P.2
Bukowski, R.3
-
18
-
-
36349011365
-
Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells
-
Shinagawa N, Yamazaki K, Tamura Y, et al: Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells. Cancer Immunol Immunother 57: 165-174, 2008.
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 165-174
-
-
Shinagawa, N.1
Yamazaki, K.2
Tamura, Y.3
-
19
-
-
0035885969
-
Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice
-
Sato K, Torimoto Y, Tamura Y, et al: Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice. Blood 98: 1852-1857, 2001.
-
(2001)
Blood
, vol.98
, pp. 1852-1857
-
-
Sato, K.1
Torimoto, Y.2
Tamura, Y.3
-
20
-
-
0034328883
-
Immunotherapy of human cancer: Lessons from mice
-
Srivastava PK: Immunotherapy of human cancer: lessons from mice. Nat Immunol 1: 363-366, 2000.
-
(2000)
Nat Immunol
, vol.1
, pp. 363-366
-
-
Srivastava, P.K.1
-
21
-
-
0037683230
-
Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice
-
Kojima T, Yamazaki K, Tamura Y, et al: Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice. Hum Gene Ther 14: 715-728, 2003.
-
(2003)
Hum Gene Ther
, vol.14
, pp. 715-728
-
-
Kojima, T.1
Yamazaki, K.2
Tamura, Y.3
-
22
-
-
3142543235
-
Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96
-
Kovalchin JT, Murthy AS, Horattas MC, Guyton DP and Chandawarkar RY: Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96. Cancer Immun 1: 7, 2001.
-
(2001)
Cancer Immun
, vol.1
, pp. 7
-
-
Kovalchin, J.T.1
Murthy, A.S.2
Horattas, M.C.3
Guyton, D.P.4
Chandawarkar, R.Y.5
-
23
-
-
0036512171
-
Roles of heat-shock proteins in innate and adaptive immunity
-
Srivastava P: Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2: 185-194, 2002.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 185-194
-
-
Srivastava, P.1
-
24
-
-
33845913216
-
Intracellular and extracellular functions of heat shock proteins: Repercussions in cancer therapy
-
Schmitt E, Gehrmann M, Brunet M, Multhoff G and Garrido C: Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol 81: 15-27, 2007.
-
(2007)
J Leukoc Biol
, vol.81
, pp. 15-27
-
-
Schmitt, E.1
Gehrmann, M.2
Brunet, M.3
Multhoff, G.4
Garrido, C.5
-
25
-
-
0036214288
-
Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses
-
Srivastava P: Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20: 395-425, 2002.
-
(2002)
Annu Rev Immunol
, vol.20
, pp. 395-425
-
-
Srivastava, P.1
-
26
-
-
0034800470
-
To find the road traveled to tumor immunity: The trafficking itineraries of molecular chaperones in antigen-presenting cells
-
Berwin B and Nicchitta CV: To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells. Traffic 2: 690-697, 2001.
-
(2001)
Traffic
, vol.2
, pp. 690-697
-
-
Berwin, B.1
Nicchitta, C.V.2
-
27
-
-
0034252699
-
gp96-the immune system's Swiss army knife
-
Schild H and Rammensee HG: gp96-the immune system's Swiss army knife. Nat Immunol 1: 100-101, 2000.
-
(2000)
Nat Immunol
, vol.1
, pp. 100-101
-
-
Schild, H.1
Rammensee, H.G.2
-
28
-
-
12144290005
-
Heat shock proteins: Biological functions and clinical application as personalized vaccines for human cancer
-
Castelli C, Rivoltini L, Rini F, et al: Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother 53: 227-233, 2004.
-
(2004)
Cancer Immunol Immunother
, vol.53
, pp. 227-233
-
-
Castelli, C.1
Rivoltini, L.2
Rini, F.3
-
29
-
-
0021339151
-
The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen
-
Srivastava PK and Das MR: The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int J Cancer 33: 417-422, 1984.
-
(1984)
Int J Cancer
, vol.33
, pp. 417-422
-
-
Srivastava, P.K.1
Das, M.R.2
-
30
-
-
0037833596
-
Vaccination with heat shock protein-peptide complexes: From basic science to clinical applications
-
Hoos A and Levey DL: Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications. Expert Rev Vaccines 2: 369-379, 2003.
-
(2003)
Expert Rev Vaccines
, vol.2
, pp. 369-379
-
-
Hoos, A.1
Levey, D.L.2
-
31
-
-
0001739064
-
Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line
-
Gross L: Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res: 323-326 1943.
-
(1943)
Cancer Res
, pp. 323-326
-
-
Gross, L.1
-
32
-
-
78651120598
-
Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host
-
Klein G, Sjogren HO, Klein E and Hellstrom KE: Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20: 1561-1572, 1960.
-
(1960)
Cancer Res
, vol.20
, pp. 1561-1572
-
-
Klein, G.1
Sjogren, H.O.2
Klein, E.3
Hellstrom, K.E.4
-
33
-
-
70449193189
-
Immunity to methylcholanthrene-induced sarcomas
-
Prehn RT and Main JM: Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18: 769-778, 1957.
-
(1957)
J Natl Cancer Inst
, vol.18
, pp. 769-778
-
-
Prehn, R.T.1
Main, J.M.2
-
35
-
-
0012846831
-
A mouse tumor-specific transplantation antigen is a heat shock-related protein
-
Ullrich SJ, Robinson EA, Law LW, Willingham M and Appella E: A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc Natl Acad Sci USA 83: 3121-3125, 1986.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 3121-3125
-
-
Ullrich, S.J.1
Robinson, E.A.2
Law, L.W.3
Willingham, M.4
Appella, E.5
-
36
-
-
0032101221
-
Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
-
Srivastava PK, Menoret A, Basu S, Binder RJ and McQuade KL: Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8, 657-665, 1998.
-
(1998)
Immunity
, vol.8
, pp. 657-665
-
-
Srivastava, P.K.1
Menoret, A.2
Basu, S.3
Binder, R.J.4
McQuade, K.L.5
-
37
-
-
0028301079
-
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70
-
Udono H and Srivastava PK: Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J Immunol 152: 5398-5403, 1994.
-
(1994)
J Immunol
, vol.152
, pp. 5398-5403
-
-
Udono, H.1
Srivastava, P.K.2
-
38
-
-
0023228980
-
5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors
-
Srivastava PK, Chen YT and Old LJ: 5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proc Natl Acad Sci USA 84: 3807-3811, 1987.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 3807-3811
-
-
Srivastava, P.K.1
Chen, Y.T.2
Old, L.J.3
-
39
-
-
0026069595
-
Stress-induced proteins in immune response to cancer
-
Srivastava PK and Maki RG: Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol 167: 109-123, 1991.
-
(1991)
Curr Top Microbiol Immunol
, vol.167
, pp. 109-123
-
-
Srivastava, P.K.1
Maki, R.G.2
-
40
-
-
0029937037
-
Structural analysis of substrate binding by the molecular chaperone DnaK
-
Zhu X, Zhao X, Burkholder WF, et al: Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272: 1606-1614, 1996.
-
(1996)
Science
, vol.272
, pp. 1606-1614
-
-
Zhu, X.1
Zhao, X.2
Burkholder, W.F.3
-
41
-
-
0032489016
-
The Hsp70 and Hsp60 chaperone machines
-
Bukau B and Horwich AL: The Hsp70 and Hsp60 chaperone machines. Cell 92: 351-366, 1998.
-
(1998)
Cell
, vol.92
, pp. 351-366
-
-
Bukau, B.1
Horwich, A.L.2
-
42
-
-
0027260585
-
Heat shock protein 70-associated peptides elicit specific cancer immunity
-
Udono H and Srivastava PK: Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178: 1391-1396, 1993.
-
(1993)
J Exp Med
, vol.178
, pp. 1391-1396
-
-
Udono, H.1
Srivastava, P.K.2
-
43
-
-
0033819308
-
Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: A pilot study
-
Janetzki S, Palla D, Rosenhauer V, Lochs H, Lewis JJ and Srivastava PK: Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer 88: 232-238, 2000.
-
(2000)
Int J Cancer
, vol.88
, pp. 232-238
-
-
Janetzki, S.1
Palla, D.2
Rosenhauer, V.3
Lochs, H.4
Lewis, J.J.5
Srivastava, P.K.6
-
44
-
-
0141955112
-
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma-and colon carcinoma-specific T cells
-
Rivoltini L, Castelli C, Carrabba M, et al: Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma-and colon carcinoma-specific T cells. J Immunol 171: 3467-3474, 2003.
-
(2003)
J Immunol
, vol.171
, pp. 3467-3474
-
-
Rivoltini, L.1
Castelli, C.2
Carrabba, M.3
-
45
-
-
20444448873
-
Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia
-
Li Z, Qiao Y, Liu B, et al: Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia. Clin Cancer Res 11: 4460-4468, 2005.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4460-4468
-
-
Li, Z.1
Qiao, Y.2
Liu, B.3
-
46
-
-
0030775140
-
Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity
-
Blachere NE, Li Z, Chandawarkar RY, et al: Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 186: 1315-1322, 1997.
-
(1997)
J Exp Med
, vol.186
, pp. 1315-1322
-
-
Blachere, N.E.1
Li, Z.2
Chandawarkar, R.Y.3
-
47
-
-
0033903196
-
Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity
-
Martin S, Lappin MB, Kohler J, et al: Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol 115: 260-266, 2000.
-
(2000)
J Invest Dermatol
, vol.115
, pp. 260-266
-
-
Martin, S.1
Lappin, M.B.2
Kohler, J.3
-
48
-
-
0034987197
-
Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice
-
Abiru N, Maniatis AK, Yu L, et al: Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice. Diabetes 50: 1274-1281, 2001.
-
(2001)
Diabetes
, vol.50
, pp. 1274-1281
-
-
Abiru, N.1
Maniatis, A.K.2
Yu, L.3
-
49
-
-
0028366212
-
Heat shock proteins transfer peptides during antigen processing and CTL priming
-
Srivastava PK, Udono H, Blachere NE and Li Z: Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39: 93-98, 1994.
-
(1994)
Immunogenetics
, vol.39
, pp. 93-98
-
-
Srivastava, P.K.1
Udono, H.2
Blachere, N.E.3
Li, Z.4
-
51
-
-
0035070198
-
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin
-
Basu S, Binder RJ, Ramalingam T and Srivastava PK: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70 and calreticulin. Immunity 14: 303-313, 2001.
-
(2001)
Immunity
, vol.14
, pp. 303-313
-
-
Basu, S.1
Binder, R.J.2
Ramalingam, T.3
Srivastava, P.K.4
-
52
-
-
0028979675
-
A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
-
Suto R and Srivastava PK: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269: 1585-1588, 1995.
-
(1995)
Science
, vol.269
, pp. 1585-1588
-
-
Suto, R.1
Srivastava, P.K.2
-
53
-
-
0034608387
-
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis
-
Singh-Jasuja H, Toes RE, Spee P, et al: Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 191: 1965-1974, 2000.
-
(2000)
J Exp Med
, vol.191
, pp. 1965-1974
-
-
Singh-Jasuja, H.1
Toes, R.E.2
Spee, P.3
-
54
-
-
84886792366
-
CD91 is involved in MHC class II presentation of gp96-chaperoned peptides
-
Matsutake T and Srivastava PK: CD91 is involved in MHC class II presentation of gp96-chaperoned peptides. Cell Stress Chaperones: 378, 2000.
-
Cell Stress Chaperones
, vol.378
, pp. 2000
-
-
Matsutake, T.1
Srivastava, P.K.2
-
55
-
-
0033747044
-
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway
-
Basu S, Binder RJ, Suto R, Anderson KM and Srivastava PK: Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12: 1539-1546, 2000.
-
(2000)
Int Immunol
, vol.12
, pp. 1539-1546
-
-
Basu, S.1
Binder, R.J.2
Suto, R.3
Anderson, K.M.4
Srivastava, P.K.5
-
56
-
-
0034812563
-
Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: Hsp60-mediated activation of cytotoxic T cells
-
Moré SH, Breloer M and von Bonin A: Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: Hsp60-mediated activation of cytotoxic T cells. Int Immunol 13: 1121-1127, 2001.
-
(2001)
Int Immunol
, vol.13
, pp. 1121-1127
-
-
Moré, S.H.1
Breloer, M.2
von Bonin, A.3
-
57
-
-
0033976502
-
Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity
-
Lehner T, Bergmeier LA, Wang Y, et al: Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol 30: 594-603, 2000.
-
(2000)
Eur J Immunol
, vol.30
, pp. 594-603
-
-
Lehner, T.1
Bergmeier, L.A.2
Wang, Y.3
-
58
-
-
0037087398
-
Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs
-
Panjwani NN, Popova L and Srivastava PK: Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J Immunol 168: 2997-3003, 2002.
-
(2002)
J Immunol
, vol.168
, pp. 2997-3003
-
-
Panjwani, N.N.1
Popova, L.2
Srivastava, P.K.3
-
59
-
-
0033839045
-
The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor
-
Singh-Jasuja H, Scherer HU, Hilf N, et al: The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30: 2211-2215, 2000.
-
(2000)
Eur J Immunol
, vol.30
, pp. 2211-2215
-
-
Singh-Jasuja, H.1
Scherer, H.U.2
Hilf, N.3
-
60
-
-
0034541171
-
Cutting edge: Heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo
-
Binder RJ, Anderson KM, Basu S and Srivastava PK: Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol 165: 6029-6035, 2000.
-
(2000)
J Immunol
, vol.165
, pp. 6029-6035
-
-
Binder, R.J.1
Anderson, K.M.2
Basu, S.3
Srivastava, P.K.4
-
61
-
-
0036219012
-
Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses
-
Ciupitu AM, Petersson M, Kono K, Charo J and Kiessling R: Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses. Cancer Immunol Immunother 51: 163-170, 2002.
-
(2002)
Cancer Immunol Immunother
, vol.51
, pp. 163-170
-
-
Ciupitu, A.M.1
Petersson, M.2
Kono, K.3
Charo, J.4
Kiessling, R.5
-
62
-
-
0037011072
-
GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression
-
Baker-LePain JC, Sarzotti M, Fields TA, Li CY and Nicchitta CV: GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J Exp Med 196: 1447-1459, 2002.
-
(2002)
J Exp Med
, vol.196
, pp. 1447-1459
-
-
Baker-LePain, J.C.1
Sarzotti, M.2
Fields, T.A.3
Li, C.Y.4
Nicchitta, C.V.5
-
63
-
-
33847615131
-
Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro
-
Li G, Zeng Y, Chen X, et al: Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro. Clin Exp Immunol 148: 136-145, 2007.
-
(2007)
Clin Exp Immunol
, vol.148
, pp. 136-145
-
-
Li, G.1
Zeng, Y.2
Chen, X.3
-
64
-
-
33646348754
-
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients
-
Pilla L, Patuzzo R, Rivoltini L, et al: A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients. Cancer Immunol Immunother 55: 958-968, 2006.
-
(2006)
Cancer Immunol Immunother
, vol.55
, pp. 958-968
-
-
Pilla, L.1
Patuzzo, R.2
Rivoltini, L.3
-
65
-
-
84879316426
-
Purification, preparation and use of chaperone-peptide complexes for tumor immunotherapy
-
Murshid A, Gong J and Calderwood SK: Purification, preparation and use of chaperone-peptide complexes for tumor immunotherapy. Methods Mol Biol 960: 209-217, 2013.
-
(2013)
Methods Mol Biol
, vol.960
, pp. 209-217
-
-
Murshid, A.1
Gong, J.2
Calderwood, S.K.3
-
66
-
-
84868095291
-
A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes
-
Gao Y, Chen X, Gao W, Yang Y, Ma H and Ren X: A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes. Oncol Rep 28: 1977-1983, 2012.
-
(2012)
Oncol Rep
, vol.28
, pp. 1977-1983
-
-
Gao, Y.1
Chen, X.2
Gao, W.3
Yang, Y.4
Ma, H.5
Ren, X.6
-
67
-
-
33750359212
-
Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells
-
Enomoto Y, Bharti A, Khaleque AA, et al: Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J Immunol 177: 5946-5955, 2006.
-
(2006)
J Immunol
, vol.177
, pp. 5946-5955
-
-
Enomoto, Y.1
Bharti, A.2
Khaleque, A.A.3
-
68
-
-
73949095492
-
A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use
-
Gong J, Zhang Y, Durfee J, et al: A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. J Immunol 184: 488-496, 2010.
-
(2010)
J Immunol
, vol.184
, pp. 488-496
-
-
Gong, J.1
Zhang, Y.2
Durfee, J.3
|